Evidence map›Paper›PMID 26056481›Full record

ReviewInfection and drug resistance2015

Corynebacterium urealyticum: a comprehensive review of an understated organism.

Nagla Salem, Lamyaa Salem, Sally Saber, Ghada Ismail, Martin H Bluth

Open access · goldAbstract readReview
In one paragraph

Review in Infection and drug resistance, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. [Emergent presence of slow-growing microorganisms in urine cultures. Clinical and microbiological analysis].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Article
  8. Encrusted pyelitis and hyperammonemia due to Corynebacterium urealyticum in a kidney transplant recipient.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Description of Corynebacterium hiratae sp. nov. isolated from a human tissue bone a novel member of Corynebacterium Genus.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  13. Preanalytical, Analytical and Postanalytical Analyses onDiagnostics (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Corynebacterium guaraldiae sp. nov.: a new species of Corynebacterium from human infections.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Nagla SalemDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Lamyaa SalemDepartment of Clinical and Chemical Pathology, Ain Shams University, Cairo, Egypt.
Sally SaberDepartment of Clinical and Chemical Pathology, Ain Shams University, Cairo, Egypt.
Ghada IsmailDepartment of Clinical and Chemical Pathology, Ain Shams University, Cairo, Egypt.
Martin H BluthDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Ain Shams University · EGWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corynebacterium urealyticum is a Gram positive, slow-growing, lipophilic, multi-drug resistant, urease positive micro-organism with diphtheroid morphology. It has been reported as an opportunistic nosocomial pathogen and as the cause of a variety of diseases including but not limited to cystitis, pyelonephritis, and bacteremia among others. This review serves to describe C. urealyticum with respect to its history, identification, laboratory investigation, relationship to disease and treatment in order to allow increased familiarity with this organism in clinical disease.

Indexed as

bacteremiaCorynebacterium urealyticumcystitismicroorganismspyelonephritis

Identifiers

PMID26056481
PMCPMC4445954
OpenAlexW2166405237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.